Cargando…
Pharmacogenomics in pulmonary arterial hypertension: Toward a mechanistic, target-based approach to therapy
Pharmacogenomics is the study of how genetic variations influence the response to drugs, by correlating gene expression with the drug's efficacy and toxicity. This concept has recently been successfully applied in oncology. To test its applicability to PAH, we examined two experimental models o...
Autores principales: | Said, Sami I., Hamidi, Sayyed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224430/ https://www.ncbi.nlm.nih.gov/pubmed/22140628 http://dx.doi.org/10.4103/2045-8932.87306 |
Ejemplares similares
-
VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension
por: Hamidi, Sayyed A, et al.
Publicado: (2011) -
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
por: Coons, James C, et al.
Publicado: (2023) -
The Pharmacogenomics of Anti-Hypertensive Therapy
por: Padmanabhan, Sandosh, et al.
Publicado: (2010) -
A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension
por: Coons, James C., et al.
Publicado: (2021) -
Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)